High-throughput metabolic stability studies in drug discovery by orthogonal acceleration time-of-flight (OATOF) with analogue-to-digital signal capture (ADC).

Screening assays capable of performing quantitative analysis on hundreds of compounds per week are used to measure metabolic stability during early drug discovery. Modern orthogonal acceleration time-of-flight (OATOF) mass spectrometers equipped with analogue-to-digital signal capture (ADC) now offer performance levels suitable for many applications normally supported by triple quadruple instruments operated in multiple reaction monitoring (MRM) mode. Herein the merits of MRM and OATOF with ADC detection are compared for more than 1000 compounds screened in rat and/or cryopreserved human hepatocytes over a period of 3 months. Statistical comparison of a structurally diverse subset indicated good agreement for the two detection methods. The overall success rate was higher using OATOF detection and data acquisition time was reduced by around 20%. Targeted metabolites of diazepam were detected in samples from a CLint determination performed at 1 microM. Data acquisition by positive and negative ion mode switching can be achieved on high-performance liquid chromatography (HPLC) peak widths as narrow as 0.2 min (at base), thus enabling a more comprehensive first pass analysis with fast HPLC gradients. Unfortunately, most existing OATOF instruments lack the software tools necessary to rapidly convert the huge amounts of raw data into quantified results. Software with functionality similar to open access triple quadrupole systems is needed for OATOF to truly compete in a high-throughput screening environment.

[1]  R. Austin,et al.  A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES , 2005, Drug Metabolism and Disposition.

[2]  M. Orsale,et al.  High-Throughput Microsomal Stability Assay for Screening New Chemical Entities in Drug Discovery , 2008, Journal of biomolecular screening.

[3]  I. Mutton.  Use of short columns and high flow rates for rapid gradient reversed-phase chromatography , 1998 .

[4]  E. Nägele,et al.  Simultaneous determination of metabolic stability and identification of buspirone metabolites using multiple column fast liquid chromatography time-of-flight mass spectrometry. , 2007, Journal of chromatography. A.

[5]  Walter A. Korfmacher,et al.  Optimizing an ultrafast generic high-performance liquid chromatography/tandem mass spectrometry method for faster discovery pharmacokinetic sample throughput. , 2005, Rapid communications in mass spectrometry : RCM.

[6]  R. King,et al.  Description and validation of a staggered parallel high performance liquid chromatography system for good laboratory practice level quantitative analysis by liquid chromatography/tandem mass spectrometry. , 2002, Rapid communications in mass spectrometry : RCM.

[7]  Mark Wrona,et al.  'All-in-one' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching. , 2005, Rapid communications in mass spectrometry : RCM.

[8]  M. Bartlett,et al.  Quantitative liquid chromatography/time-of-flight mass spectrometry. , 2007, Biomedical chromatography : BMC.

[9]  Walter A. Korfmacher,et al.  Increasing speed and throughput when using HPLC-MS/MS systems for drug metabolism and pharmacokinetic screening. , 2006, Current drug metabolism.

[10]  T N Thompson,et al.  Early ADME in support of drug discovery: the role of metabolic stability studies. , 2000, Current drug metabolism.

[11]  T. Baillie,et al.  Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. , 2004, Chemical research in toxicology.

[12]  Ernesto Callegari,et al.  A comprehensive listing of bioactivation pathways of organic functional groups. , 2005, Current drug metabolism.

[13]  Douglas G. Altman,et al.  Measurement in Medicine: The Analysis of Method Comparison Studies , 1983 .

[14]  Kiyomi Ito,et al.  Comparison of the Use of Liver Models for Predicting Drug Clearance Using in Vitro Kinetic Data from Hepatic Microsomes and Isolated Hepatocytes , 2004, Pharmaceutical Research.

[15]  Hannah M Jones,et al.  SUBSTRATE DEPLETION APPROACH FOR DETERMINING IN VITRO METABOLIC CLEARANCE: TIME DEPENDENCIES IN HEPATOCYTE AND MICROSOMAL INCUBATIONS , 2004, Drug Metabolism and Disposition.

[16]  I. Chernushevich,et al.  An introduction to quadrupole-time-of-flight mass spectrometry. , 2001, Journal of mass spectrometry : JMS.

[17]  Jennifer H Granger,et al.  Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. , 2005, Rapid communications in mass spectrometry : RCM.

[18]  Y. Hsieh.  HPLC-MS/MS in drug metabolism and pharmacokinetic screening , 2008, Expert opinion on drug metabolism & toxicology.

[19]  K. Valko,et al.  High-throughput physicochemical and in vitro ADMET screening , 2005 .

[20]  Sean Yu,et al.  High-throughput, accurate mass liquid chromatography/tandem mass spectrometry on a quadrupole time-of-flight system as a 'first-line' approach for metabolite identification studies. , 2008, Rapid communications in mass spectrometry : RCM.

[21]  J. T. Wu.  The development of a staggered parallel separation liquid chromatography/tandem mass spectrometry system with on-line extraction for high-throughout screening of drug candidates in biological fluids. , 2001, Rapid communications in mass spectrometry : RCM.

[22]  H. van de Waterbeemd,et al.  Property-based design: optimization of drug absorption and pharmacokinetics. , 2001, Journal of medicinal chemistry.

[23]  A. Nassar,et al.  Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability. , 2004, Drug discovery today.

[24]  Desmond O'Connor,et al.  Ultra-performance liquid chromatography coupled to time-of-flight mass spectrometry for robust, high-throughput quantitative analysis of an automated metabolic stability assay, with simultaneous determination of metabolic data. , 2006, Rapid communications in mass spectrometry : RCM.

[25]  J. Halladay,et al.  Metabolic stability screen for drug discovery using cassette analysis and column switching. , 2007, Drug metabolism letters.

[26]  D. T. Rossi,et al.  Quantification and rapid metabolite identification in drug discovery using API time-of-flight LC/MS. , 2000, Analytical chemistry.